KIMBERLY HOSTE: Open Payments
NPI 1285245969 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,327 in 75 payments from 24 companies in 2025. Trend: 2023 $128 · 2024 $56 · 2025 $1,327
Food & beverage: $1,327
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $179 |
| ABBVIE INC. | 12 | $141 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $122 |
| Lilly USA, LLC | 5 | $118 |
| Otsuka America Pharmaceutical, Inc. | 5 | $111 |
| PFIZER INC. | 5 | $86 |
| Amgen Inc. | 5 | $83 |
| Exact Sciences Corporation | 3 | $56 |
| Insulet Corporation | 3 | $53 |
| Astellas Pharma US Inc | 2 | $48 |
Products named: Kerendia, MOUNJARO, REXULTI, Ozempic, NURTEC ODT, OTEZLA, UBRELVY, Wegovy.
Industry payments across AZ — which companies pay providers there.
